Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the control of type 2 diabetes. This man-made peptide duplicates the actions of naturally occurring GLP-1, a https://checkbookmarks.com/story6466471/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes